NovoCure Limited (NVCR) Revenue by Year

NVCR

NovoCure Limited generated $655.4M in revenue in fiscal year 2025. This represents an increase of 8.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $699.2M in revenue. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters NovoCure Limited has filed alongside them.

FY2025 annual

Revenue $655.4M

YoY +8.3%

5Y CAGR +5.8%

10Y CAGR +34.8%

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 23, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NVCR Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2510-Q	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Revenue	$699.2M	$655.4M+8.3%	$605.2M+18.8%	$509.3M-5.3%	$537.8M+0.5%	$535.0M+8.2%	$494.4M+40.7%	$351.3M+41.6%	$248.1M+40.1%	$177.0M+113.6%	$82.9M+150.5%	$33.1M+113.6%	$15.5M+49.5%	$10.4M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

NVCR Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Revenue	$183.6M+15.6%	$174.1M+12.3%	$174.3M+8.1%	$167.2M+7.8%	$158.8M+5.6%	$155.0M+11.9%	$161.3M+20.5%	$155.1M+21.8%	$150.4M+19.3%	$138.5M+13.4%	$133.8M+4.2%	$127.3M-2.8%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More NovoCure Limited financials

Frequently Asked Questions

What was NovoCure Limited's revenue in fiscal year 2025?

NovoCure Limited generated $655.4M in revenue in fiscal year 2025.

How fast is NovoCure Limited's revenue growing?

NovoCure Limited (NVCR) revenue rose by 8.3% year over year, from $605.2M to $655.4M in fiscal year 2025.

What is NovoCure Limited's revenue over the last twelve months?

NovoCure Limited (NVCR) reported $699.2M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

How has NovoCure Limited's revenue changed over the years?

Across the 13 fiscal years this page covers, NovoCure Limited (NVCR) revenue went from $10.4M in fiscal year 2013 to $655.4M in fiscal year 2025.

What was NovoCure Limited's revenue in the most recent quarter?

NovoCure Limited (NVCR) reported $183.6M in revenue in Q2 2026. This represents an increase of 15.6% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what NovoCure Limited (NVCR) reported on that line in every period on record.